Destiny Wealth Partners, LLC United Therapeutics Corp Transaction History

Destiny Wealth Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$166.16 - $213.96 $4,320 - $5,562	-26 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$179.86 - $214.88 $4,676 - $5,586	26 New	26 $5,000
Q2 2021 Jul 27, 2021	SELL	$170.47 - $211.93 $38,185 - $47,472	-224 Closed	0 $0
Q1 2021 Apr 22, 2021	BUY	$153.94 - $174.85 $34,482 - $39,166	224 New	224 $37,000

672

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Destiny Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Destiny Wealth Partners, LLC with notifications on news.